The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial

CONCLUSION: These findings suggest the probable efficacy of pioglitazone as an augmentation therapy in reducing the negative symptoms of schizophrenia

1 Like

These Iranian researchers always throw something new at the wall and it shows promise in the treatment of negative symptoms. I’d be wary of these results until they are replicated by more credible sources.

1 Like

Are we saying that only Australian/European/American etc researchers are to be trusted and the rest are charlatans ?

1 Like

I personally don’t trust them. It’s my personal choice :smile:

1 Like